Chorus

Nontraditional choral work wins Grawemeyer music prize

Retrieved on: 
Monday, December 4, 2023
Woman, City University, Organization, Psychology, Language, American Academy, Multimedia, Culture, Religion, Drawing, Carnegie Hall, Music, Foreign Affairs, University, Kronos Quartet, Letter, English National Ballet, Education, Grawemeyer Award, Musical composition, Life, Entertainment, San Francisco Bay Area, Chorus

LOUISVILLE, Ky., Dec. 4, 2023 /PRNewswire/ -- Serbian-American composer Aleksandra Vrebalov (VREH'-bah-lawv) has won the 2024 University of Louisville Grawemeyer Award in Music Composition for "Missa Supratext," a nontraditional choral work for string quartet and girls' chorus.

Key Points: 
  • LOUISVILLE, Ky., Dec. 4, 2023 /PRNewswire/ -- Serbian-American composer Aleksandra Vrebalov (VREH'-bah-lawv) has won the 2024 University of Louisville Grawemeyer Award in Music Composition for "Missa Supratext," a nontraditional choral work for string quartet and girls' chorus.
  • "Vrebalov's music transports and envelops the listener," said Matthew Ertz, music award director.
  • "Her winning piece emphasizes the universality of human expression through music, bypassing a single language, style or tradition.
  • She blends together diverse harmonies, rhythms, styles and improvisations, conveying her devotion to music and to the uniqueness of all things."

Nontraditional choral work wins Grawemeyer music prize

Retrieved on: 
Monday, December 4, 2023
Woman, City University, Organization, Psychology, Language, American Academy, Culture, Religion, Drawing, Carnegie Hall, Music, Foreign Affairs, University, Kronos Quartet, Letter, English National Ballet, Education, Grawemeyer Award, Musical composition, Life, Entertainment, San Francisco Bay Area, Chorus

LOUISVILLE, Ky., Dec. 4, 2023 /PRNewswire/ -- Serbian-American composer Aleksandra Vrebalov (VREH'-bah-lawv) has won the 2024 University of Louisville Grawemeyer Award in Music Composition for "Missa Supratext," a nontraditional choral work for string quartet and girls' chorus.

Key Points: 
  • LOUISVILLE, Ky., Dec. 4, 2023 /PRNewswire/ -- Serbian-American composer Aleksandra Vrebalov (VREH'-bah-lawv) has won the 2024 University of Louisville Grawemeyer Award in Music Composition for "Missa Supratext," a nontraditional choral work for string quartet and girls' chorus.
  • "Vrebalov's music transports and envelops the listener," said Matthew Ertz, music award director.
  • "Her winning piece emphasizes the universality of human expression through music, bypassing a single language, style or tradition.
  • She blends together diverse harmonies, rhythms, styles and improvisations, conveying her devotion to music and to the uniqueness of all things."

Jazz honoured with Indigenous Reconciliation award from Government of Canada

Retrieved on: 
Thursday, November 23, 2023
Aviation, Indigenous peoples, North American Indigenous Games, Policy, Learning, Government, Flight attendant, CHR, Jazz Aviation, Indigenous self-government in Canada, Affirmative action, Knowledge, TSX, Education, Management, Indigenous, Jazz, Chorus

HALIFAX, NS, Nov. 23, 2023 /CNW/ - Chorus Aviation Inc. ('Chorus') (TSX: CHR) is pleased to announce that its subsidiary Jazz Aviation LP ('Jazz') has received an inaugural year Indigenous Reconciliation award from the Government of Canada's Employment Equity Achievement Awards on November 22, 2023.

Key Points: 
  • HALIFAX, NS, Nov. 23, 2023 /CNW/ - Chorus Aviation Inc. ('Chorus') (TSX: CHR) is pleased to announce that its subsidiary Jazz Aviation LP ('Jazz') has received an inaugural year Indigenous Reconciliation award from the Government of Canada's Employment Equity Achievement Awards on November 22, 2023.
  • The Indigenous Reconciliation award recognizes employers who have demonstrated outstanding commitment to reconciliation with Indigenous peoples.
  • "Jazz is proud to have an employee base that reflects the diversity of the communities we serve," said Randolph deGooyer, President, Jazz.
  • "This is outstanding recognition for Jazz and an honour to be included in the inaugural class of award recipients for Indigenous reconciliation," said Colin Copp, President and Chief Executive Officer, Chorus.

Everest Group Names SS&C Blue Prism as a Leader and a Star Performer in Process Orchestration Products PEAK Matrix® 2023

Retrieved on: 
Tuesday, November 21, 2023
SS&C, Research, Organization, Workforce, Investment, Robotic process automation, PEAK, Insurance, Business process automation, Risk, Automation, Health, RPA, Robotics, Intelligent automation, Process, Management, Chorus

WINDSOR, Conn., Nov. 21, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced SS&C Blue Prism has been named a Leader and a Star Performer in the Everest Group Process Orchestration Products PEAK Matrix® Assessment 2023 .

Key Points: 
  • WINDSOR, Conn., Nov. 21, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced SS&C Blue Prism has been named a Leader and a Star Performer in the Everest Group Process Orchestration Products PEAK Matrix® Assessment 2023 .
  • "Strong year-over-year improvements in SS&C Blue Prism's capabilities and value delivered to its clients have helped it emerge as a Leader and a Star Performer on Everest Group's Process Orchestration Products PEAK Matrix® 2023."
  • Analyzing products, applications and strengths of 24 technology providers in the market, the Process Orchestration Products PEAK Matrix® Assessment 2023 is a key indicator of the process orchestration landscape and emerging trends.
  • In October 2023, SS&C Blue Prism was named a Robotic Process Automation (RPA) Leader in the Everest Group Robotic Process Automation (RPA) Products PEAK Matrix® Assessment 2023 for the six consecutive year in a row.

Everest Group Names SS&C Blue Prism as a Leader and a Star Performer in Process Orchestration Products PEAK Matrix® 2023

Retrieved on: 
Tuesday, November 21, 2023
SS&C, Research, Organization, Workforce, Investment, Robotic process automation, PEAK, Insurance, Business process automation, Risk, Automation, Health, RPA, Robotics, Intelligent automation, Process, Management, Chorus

WINDSOR, Conn., Nov. 21, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced SS&C Blue Prism has been named a Leader and a Star Performer in the Everest Group Process Orchestration Products PEAK Matrix® Assessment 2023 .

Key Points: 
  • WINDSOR, Conn., Nov. 21, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced SS&C Blue Prism has been named a Leader and a Star Performer in the Everest Group Process Orchestration Products PEAK Matrix® Assessment 2023 .
  • "Strong year-over-year improvements in SS&C Blue Prism's capabilities and value delivered to its clients have helped it emerge as a Leader and a Star Performer on Everest Group's Process Orchestration Products PEAK Matrix® 2023."
  • Analyzing products, applications and strengths of 24 technology providers in the market, the Process Orchestration Products PEAK Matrix® Assessment 2023 is a key indicator of the process orchestration landscape and emerging trends.
  • In October 2023, SS&C Blue Prism was named a Robotic Process Automation (RPA) Leader in the Everest Group Robotic Process Automation (RPA) Products PEAK Matrix® Assessment 2023 for the six consecutive year in a row.

Rivus Pharmaceuticals Announces Expansion of HU6 Clinical Program and New Leadership Appointments

Retrieved on: 
Wednesday, November 15, 2023
Accounting, Obesity, Manchester Metropolitan University, Safety, A1C, SAN, Magnetic resonance imaging, Epidemiology, Nutcracker, Therapy, Phenotype, Cardiology, Cirrhosis, FACC, Risk, Vertex Pharmaceuticals, Hospital, CMA, DSM-IV codes, Patient, Diabetes, Sangamo Therapeutics, Science, Pharmacokinetics, Heart failure, Syndrome, Health, Eli Lilly, Messenger, University, Public health, Massachusetts General Hospital, Body composition, Body mass index, MASH, Type 2, Human, Type 2 diabetes, Management, Pharmaceutical industry, Lilly, Chorus

CHARLOTTESVILLE, Va. and SAN FRANCISCO, Nov. 15, 2023 /PRNewswire/ -- Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving metabolic health, today announced key clinical and corporate updates. The company randomized the first patient in the Phase 2b M-ACCEL trial of HU6, an investigational controlled metabolic accelerator (CMA), in obese subjects with Type 2 diabetes and at risk of metabolic dysfunction-associated steatohepatitis (MASH). Additionally, Rivus appointed Robert J. Schott, M.D., M.P.H., FACC, chief medical officer and appointed Ian F. Smith chairman of the board of directors.

Key Points: 
  • Additionally, Rivus appointed Robert J. Schott, M.D., M.P.H., FACC, chief medical officer and appointed Ian F. Smith chairman of the board of directors.
  • Approximately 280 adult patients will be randomized 2:1:2:2 into one of four treatment groups (placebo, HU6 150 mg, HU6 300 mg or HU6 450 mg) and treated for six months (26 weeks).
  • "I am delighted to be joining Rivus Pharmaceuticals, where the devoted founders and their team have made rapid progress in advancing HU6 into the clinic," said Dr. Schott.
  • "I look forward to partnering with the Rivus leadership team and other board members as we pursue the company's mission to improve human metabolic health caused by obesity.

The Frederick Children's Chorus will perform Handel's Messiah Sing-Along on Tuesday, December 19, 2023

Retrieved on: 
Wednesday, November 8, 2023
Messiah (Handel), Human, Chorus, Rest, Entertainment

FREDERICK, Md., Nov. 8, 2023 /PRNewswire-PRWeb/ -- This year's performance will mark the 28th year that the Frederick Children's Chorus has brought this spectacular performance of Handel's Messiah Sing-Along, which has become one of the region's must-attend events each holiday season. Hundreds of fellow music lovers, a professional orchestra, 4 superstar soloists, and our magnificent stage chorus will join together for a spectacular performance that will leave everyone bursting with more holiday spirit than ever.

Key Points: 
  • FREDERICK, Md., Nov. 8, 2023 /PRNewswire-PRWeb/ -- This year's performance will mark the 28th year that the Frederick Children's Chorus has brought this spectacular performance of Handel's Messiah Sing-Along, which has become one of the region's must-attend events each holiday season.
  • Hundreds of fellow music lovers, a professional orchestra, 4 superstar soloists, and our magnificent stage chorus will join together for a spectacular performance that will leave everyone bursting with more holiday spirit than ever.
  • This Sing-Along is interactive and invites you to sing with the chorus to the majesty of the classic Handel's Messiah.
  • Your voice will soar through the concert hall with the rest of the audience, backed by live musicians and a large, on-stage choir.

Chorus Intelligence, Inc. Transitions to New Office Space in Town Center

Retrieved on: 
Wednesday, November 8, 2023
Intelligence, Law enforcement agency, History, Digital, VBPD, Economic development, Virginia Beach Police Department, Private investigator, Chorus

The company has spent the past two years renting office space from the Virginia Beach Economic Development Department within their International Incubator.

Key Points: 
  • The company has spent the past two years renting office space from the Virginia Beach Economic Development Department within their International Incubator.
  • The move to new office space will serve as the base for the next evolution of Chorus Intelligence's growth.
  • The move to new office space in Town Center will not only accommodate the company's expanding team but also will serve as the base for the next evolution of Chorus Intelligence's growth.
  • CEO Neil Chivers expressed his enthusiasm for the new office opening, saying, "The opening of our new office in Town Center, Virginia Beach is a truly outstanding moment in the history of Chorus Intelligence.

Clari Named a Strong Performer in Conversation Intelligence by Independent Research Firm

Retrieved on: 
Tuesday, October 31, 2023
Software, Mobile, Wireless, Networks, Internet, Professional Services, Business, Fintech, Data Management, Apps, Applications, Technology, Artificial Intelligence, Finance, Research, Intelligence, REVAi, Forrester, Organization, Growth, Forrester Research, Forecasting, CI, Marketing, Sales, Chorus, Clari

Clari today announced that Forrester Research has named the company a Strong Performer in “The Forrester Wave™: Conversation Intelligence For B2B Revenue, Q4 2023.” According to Forrester, “Clari is best for companies wanting an enterprise deal management solution that includes real-time conversation intelligence,” and represents “value for money” as emphasized by Clari’s many reference customers.

Key Points: 
  • Clari today announced that Forrester Research has named the company a Strong Performer in “The Forrester Wave™: Conversation Intelligence For B2B Revenue, Q4 2023.” According to Forrester, “Clari is best for companies wanting an enterprise deal management solution that includes real-time conversation intelligence,” and represents “value for money” as emphasized by Clari’s many reference customers.
  • This Forrester evaluation follows Clari being named a Leader in “The Forrester Wave™: Revenue Operations and Intelligence, Q1 2022” report, as well as Groove, a Clari company, being named a Leader in “The Forrester Wave™: Sales Engagement Platforms, Q3 2022” report.
  • The Conversation Intelligence Forrester Wave evaluated Clari’s Conversation Intelligence (CI) solution, Clari Copilot , and 11 other providers across 25 criteria.
  • Copilot goes beyond the limits of similar conversation intelligence tools by helping revenue-centric teams act in the moment when it matters.

BioAge Labs Announces Plans for Phase 2 Trial of First-in-Class Apelin Receptor Agonist BGE-105/Azelaprag Co-Administered With Tirzepatide for Treatment of Obesity, in Collaboration With Lilly’s Chorus Organization

Retrieved on: 
Thursday, October 26, 2023
Health, Fitness & Nutrition, Clinical Trials, General Health, Pharmaceutical, Biotechnology, Science, Lilly, Eli Lilly and Company, Ageing, Concept, Biomarker, Therapy, Heart, Obesity, Weight loss, Apelin, Doctor of Philosophy, Agonal respiration, Maintenance, Exercise, Metabolism, Drug development, Incretin, Muscle atrophy, Biology, Amgen, Bed rest, Chemistry, Central nervous system, Pharmaceutical industry, Dietary supplement, Chorus

As part of the collaboration, Lilly will also provide BioAge with tirzepatide.

Key Points: 
  • As part of the collaboration, Lilly will also provide BioAge with tirzepatide.
  • “We are thrilled to work directly with the clinical development experts at Chorus and benefit from Lilly’s expertise in obesity drug development,” said Kristen Fortney, PhD, CEO and co-founder of BioAge.
  • “Our Phase 2 trial is designed to assess whether azelaprag can substantially increase the weight loss achieved with drugs of the incretin class.
  • Apelin signaling has demonstrated multiple benefits in energy metabolism in mouse models, including increased insulin sensitivity and reduction in fat mass.